LEON SCHWARTZ, M.D.; HARRISON F. FLIPPIN, M.D.; WILLIAM G. TURNBULL, M.D.
During the past few years a number of significant contributions to the therapy of pneumococcic pneumonia have been made. Cole1 and his co-workers and others2, 3, 4 have demonstrated the efficacy of serum therapy. More recently, sulfapyridine5 has been found to be highly effective against the pneumococcus, and from early reports6, 7 it seems to be of unquestioned value in the treatment of pneumonia due to this organism. Both sero- and chemotherapy have gained many advocates, although there are still some8 who rely on non-specific remedies and claim equally good results. To evaluate the comparative merits of the various therapeutic
SCHWARTZ L, FLIPPIN HF, TURNBULL WG. TREATMENT OF PNEUMOCOCCIC PNEUMONIA; A COMPARATIVE STUDY OF 351 PATIENTS TREATED AT THE PHILADELPHIA GENERAL HOSPITAL1. Ann Intern Med. ;13:1005–1012. doi: 10.7326/0003-4819-13-6-1005
Download citation file:
Published: Ann Intern Med. 1939;13(6):1005-1012.
Hospital Medicine, Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use